These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5350915)

  • 21. [BCG vaccination: characteristics of drugs and causes of vaccinal complications].
    Levi DT; Aksenova VA; Zakirova NR; Aleksandrova NV
    Probl Tuberk; 1999; (4):4-7. PubMed ID: 10479921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Waning of post vaccinial allergy after neonatal BCG vaccination.
    Chhatwal J; Verma M; Thaper N; Aneja R
    Indian Pediatr; 1994 Dec; 31(12):1529-33. PubMed ID: 7875813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of Bacillus Calmette-Guèrin vaccination at birth and 2 months old age on the peripheral blood T-cell subpopulations [gamma/delta and alpha-beta T cell].
    Taştan Y; Arvas A; Demir G; Alikaşifoğlu M; Gür E; Kiray E
    Pediatr Allergy Immunol; 2005 Dec; 16(8):624-9. PubMed ID: 16343082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between the development of dermal scar at the site of BCG vaccination and post-vaccinal allergy].
    Paizier RD
    Probl Tuberk; 1975; (7):12-4. PubMed ID: 1215365
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative study of Polish, Russian and Hungarian BCG vaccines. II. Evaluation of the allergenic properties of the vaccines after 26 weeks and 30 months].
    Szczuka I; Olakowski T
    Pneumonol Pol; 1983; 51(8-9):449-59. PubMed ID: 6647052
    [No Abstract]   [Full Text] [Related]  

  • 26. [BCG vaccination using intradermal Akra injector. III. Results of measurements of post-vaccination scars 12 months after vaccination and comparison of results after 6 and 12 months].
    Mardoñ K; Olakowski T
    Gruzlica; 1971 Nov; 39(11):1063-71. PubMed ID: 5137647
    [No Abstract]   [Full Text] [Related]  

  • 27. [BCG vaccination, Critical study (author's transl)].
    Alcaide Megías J; Altet Gómez MN; Boqué Genovard MA
    An Esp Pediatr; 1982 Feb; 16(2):95-101. PubMed ID: 6979280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of mass BCG vaccination at birth on the incidence of tuberculosis among Jewish children in Israel.
    Zilber N; Simchen E; Wartski S; Marcus JH; Shakya GR
    Isr J Med Sci; 1984 Dec; 20(12):1150-7. PubMed ID: 6519946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study of Polish, Russian and Hungarian BCG vaccines. I. Evaluation of the allergenic properties of the vaccines after 16 weeks].
    Szczuka I; Olakowski T
    Pneumonol Pol; 1983; 51(8-9):441-7. PubMed ID: 6647051
    [No Abstract]   [Full Text] [Related]  

  • 30. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
    Szczuka I
    Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infant BCG vaccination study in Lithuania.
    Suciliene E; Rønne T; Plesner AM; Semenaite B; Slapkauskaite D; Larsen SO; Hasløv K
    Int J Tuberc Lung Dis; 1999 Nov; 3(11):956-61. PubMed ID: 10587317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do different vaccination regimens for BCG and hepatitis B affect the development of allergic disorders in early childhood?
    Dilli D; Bostanci I; Dallar Y
    J Asthma; 2008 Mar; 45(2):155-9. PubMed ID: 18350408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evolution of BCG post-vaccination allergy and related defense mechanisms].
    Norska I
    Gruzlica; 1966 Feb; 34(2):121-9. PubMed ID: 5943373
    [No Abstract]   [Full Text] [Related]  

  • 34. [Correlation of post-vaccinal allergy and the size of the vaccinal scars in B.C.G. vaccination].
    Dumitrache P; Munteanu S; Sava G
    Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit; 1981 Jun; 29(6):121-7. PubMed ID: 6795800
    [No Abstract]   [Full Text] [Related]  

  • 35. Adverse reactions to BCG.
    Vítková E; Galliová J; Krepela K; Kubín M
    Cent Eur J Public Health; 1995 Aug; 3(3):138-41. PubMed ID: 8535371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCG vaccination in BCG scar negative children.
    Goyal R
    Indian Pediatr; 1998 Jun; 35(6):569-71. PubMed ID: 10216662
    [No Abstract]   [Full Text] [Related]  

  • 37. Cattle as a model for development of vaccines against human tuberculosis.
    Buddle BM; Skinner MA; Wedlock DN; de Lisle GW; Vordermeier HM; Glyn Hewinson R
    Tuberculosis (Edinb); 2005; 85(1-2):19-24. PubMed ID: 15687023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Controlled studies on the BCG vaccines. I. Studies on the occurrence of tuberculin induction (booster effect)].
    Olakowski T; Mardoń K
    Gruzlica; 1969 Jun; 37(6):489-501. PubMed ID: 5350914
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of bacille Calmette-Guérin vaccination at birth on tuberculin skin test reactivity in Ugandan children.
    Mudido PM; Guwatudde D; Nakakeeto MK; Bukenya GB; Nsamba D; Johnson JL; Mugerwa RD; Ellner JJ; Whalen CC
    Int J Tuberc Lung Dis; 1999 Oct; 3(10):891-5. PubMed ID: 10524586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.